Kairos Pharma outlines 2024 achievements and 2025 goals
LOS ANGELES - Kairos Pharma Ltd. (NYSE American: KAPA), a biopharmaceutical company specializing in cancer treatment therapies, has announced its key milestones from 2024 and provided an outlook for ...
mccaravan6d
Kairos leaders gain deeper understanding of leadership
Kairos is Greek for “the right time,” and every year Mount Carmel invites the senior class to join. Typically Mr. Matt ...
Boston College6d
BC Kairos marks 25th anniversary
Some 10,000 BC students have participated in the formative and popular retreat since its inception Boston College will mark the 25th anniversary of the formative and wildly popular Kairos retreat ...
Business Wire17d
Kairos Pharma Provides Business Update and Outlook into 2025
provides an overview of key 2024 milestones and outlook into 2025 in a Letter to Shareholders: Dear Kairos Pharma Shareholders, The management team and Board of Directors of Kairos Pharma Ltd. are ...
world-nuclear-news7d
Kairos Power fabricates and installs test unit reactor vessel
The central component for the second-iteration test unit for Kairos Power's Hermes reactor is the first reactor vessel to be ...